Creabilis
http://www.creabilis-sa.com/Overview
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 4
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jan 12, 2015 | Creabilis Receives Positive Feedback on CT327 from US FDA, Providing Clear Path to Registration | Creabilis Ltd, the dermatology company with the most advanced targeted topical treatment in development for chronic pruritus (itch), announces that it has received positive feedback from the US Food and Drug Administration (FDA) on its lead... |
| Oct 4, 2011 | Creabilis Raises €15M in Series B Funding | Creabilis SA, a Luxembourg-based clinical stage biotechnology company dedicated to creating new drugs to tackle dermatology and inflammatory diseases dermatology, has raised €15m ($20m) in a Series B funding. The round was led by Abbott Bio... |
| Oct 4, 2011 | Creabilis Raises $20M in Series B | Funding led by Abbott Biotech Ventures. Existing investors Neomed and Sofinnova Partners, as well as private Italian investors, joined the round. >> Click here for more funding data on Creabilis >> To export Creabilis fundin... |
Reviews 0
FAQ about Creabilis
When was Creabilis founded?
Creabilis was founded in 2003.
How much funding has Creabilis raised?
Creabilis has raised $20M in total across 1 funding round.
What has the press written about Creabilis?
Parsers VC has collected 4 articles mentioning Creabilis, among them “Creabilis Receives Positive Feedback on CT327 from US FDA, Providing Clear Path to Registration” (Jan 12, 2015) and “Creabilis Raises €15M in Series B Funding” (Oct 4, 2011).
Is Creabilis still active?
Creabilis is probably closed: its latest activity on Parsers VC dates from Dec 8, 2016.